Evidence map›Paper›PMID 24685274›Full record

ArticleActa neuropathologica communications2014

Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres.

Dacheng Ding, Kah Suan Lim, Charles G Eberhart

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Autophagy as a Potential Therapy for Malignant Glioma.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  14. Arsenic trioxide as a novel anti-glioma drug: a review.Cellular & molecular biology letters · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Dacheng Ding
Kah Suan Lim
Charles G EberhartDepartments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. ceberha@jhmi.edu.
Johns Hopkins University · USCentral South University · CN

Funding

Notch signaling in brain tumorsR01NS055089 · NINDS · JOHNS HOPKINS UNIVERSITY · PI EBERHART, CHARLES G · 2007 to 2016
$3.2M
NINDS NIH HHS R01 NS055089NINDS NIH HHS R01NS055089
6 · The paper itself

Abstract

backgroundNotch and Hedgehog signaling have been implicated in the pathogenesis and stem-like characteristics of glioblastomas, and inhibitors of the pathways have been suggested as new therapies for these aggressive tumors. It has also been reported that targeting both pathways simultaneously can be advantageous in treating glioblastoma neurospheres, but this is difficult to achieve in vivo using multiple agents. Since arsenic trioxide has been shown to inhibit both Notch and Hedgehog in some solid tumors, we examined its effects on these pathways and on stem cell phenotype in glioblastoma.

resultsWe found that arsenic trioxide suppresses proliferation and promotes apoptosis in three stem-like glioblastoma neurospheres lines, while inhibiting Notch and Hedgehog target genes. Importantly, arsenic trioxide markedly reduced clonogenic capacity of the tumor neurospheres, and the stem-like CD133-positive fraction was also diminished along with expression of the stem cell markers SOX2 and CD133.

conclusionsOur results suggest that arsenic trioxide may be effective in targeting stem-like glioblastoma cells in patients by inhibiting Notch and Hedgehog activity.

Indexed as

Antineoplastic AgentsApoptosisArsenicalsArsenic TrioxideCell CycleCell Growth ProcessesCell Line, TumorCell ProliferationColony-Forming Units AssayDose-Response Relationship, DrugFlow CytometryGene Expression Regulation, NeoplasticGlial Fibrillary Acidic ProteinGlioblastomaHedgehog ProteinsHumansAntineoplastic AgentsArsenicalsArsenic TrioxideGlial Fibrillary Acidic ProteinHedgehog ProteinsOxidesReceptors, Notch

Identifiers

PMID24685274
PMCPMC3977902
OpenAlexW2149433168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.